Company Details
charles-river-laboratories
14,665
201,791
541714
criver.com
0
CHA_1163479
In-progress

Charles River Laboratories Company CyberSecurity Posture
criver.comAt Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Company Details
charles-river-laboratories
14,665
201,791
541714
criver.com
0
CHA_1163479
In-progress
Between 750 and 799

CRL Global Score (TPRM)XXXX



No incidents recorded for Charles River Laboratories in 2025.
No incidents recorded for Charles River Laboratories in 2025.
No incidents recorded for Charles River Laboratories in 2025.
CRL cyber incidents detection timeline including parent company and subsidiaries

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL


NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
.png)
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter.
Charles River Laboratories has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on...
WILMINGTON, Mass., November 17, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it...
Charles River Laboratories' third quarter results were met with negative market reaction, as investors focused on the company's muted...
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented...
Charles River Laboratories International (CRL) shares edged up slightly, with investors watching for updates that could guide the laboratory...
Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on...
Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported...
Announces Steps to Strengthen and Refine Portfolio and to Maximize Financial Performance –. WILMINGTON, Mass., November 05, 2025--(BUSINESS...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Charles River Laboratories is http://criver.com.
According to Rankiteo, Charles River Laboratories’s AI-generated cybersecurity score is 777, reflecting their Fair security posture.
According to Rankiteo, Charles River Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Charles River Laboratories is not certified under SOC 2 Type 1.
According to Rankiteo, Charles River Laboratories does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Charles River Laboratories is not listed as GDPR compliant.
According to Rankiteo, Charles River Laboratories does not currently maintain PCI DSS compliance.
According to Rankiteo, Charles River Laboratories is not compliant with HIPAA regulations.
According to Rankiteo,Charles River Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Charles River Laboratories operates primarily in the Biotechnology Research industry.
Charles River Laboratories employs approximately 14,665 people worldwide.
Charles River Laboratories presently has no subsidiaries across any sectors.
Charles River Laboratories’s official LinkedIn profile has approximately 201,791 followers.
Charles River Laboratories is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Yes, Charles River Laboratories has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/charles-river-laboratories-international.
Yes, Charles River Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/charles-river-laboratories.
As of December 05, 2025, Rankiteo reports that Charles River Laboratories has not experienced any cybersecurity incidents.
Charles River Laboratories has an estimated 4,428 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Charles River Laboratories has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
Sigstore Timestamp Authority is a service for issuing RFC 3161 timestamps. Prior to 2.0.3, Function api.ParseJSONRequest currently splits (via a call to strings.Split) an optionally-provided OID (which is untrusted data) on periods. Similarly, function api.getContentType splits the Content-Type header (which is also untrusted data) on an application string. As a result, in the face of a malicious request with either an excessively long OID in the payload containing many period characters or a malformed Content-Type header, a call to api.ParseJSONRequest or api.getContentType incurs allocations of O(n) bytes (where n stands for the length of the function's argument). This vulnerability is fixed in 2.0.3.
Monkeytype is a minimalistic and customizable typing test. In 25.49.0 and earlier, there is improper handling of user input which allows an attacker to execute malicious javascript on anyone viewing a malicious quote submission. quote.text and quote.source are user input, and they're inserted straight into the DOM. If they contain HTML tags, they will be rendered (after some escaping using quotes and textarea tags).
SysReptor is a fully customizable pentest reporting platform. Prior to 2025.102, there is a Stored Cross-Site Scripting (XSS) vulnerability allows authenticated users to execute malicious JavaScript in the context of other logged-in users by uploading malicious JavaScript files in the web UI. This vulnerability is fixed in 2025.102.
Taiko Alethia is an Ethereum-equivalent, permissionless, based rollup designed to scale Ethereum without compromising its fundamental properties. In 2.3.1 and earlier, TaikoInbox._verifyBatches (packages/protocol/contracts/layer1/based/TaikoInbox.sol:627-678) advanced the local tid to whatever transition matched the current blockHash before knowing whether that batch would actually be verified. When the loop later broke (e.g., cooldown window not yet passed or transition invalidated), the function still wrote that newer tid into batches[lastVerifiedBatchId].verifiedTransitionId after decrementing batchId. Result: the last verified batch could end up pointing at a transition index from the next batch (often zeroed), corrupting the verified chain pointer.
A flaw has been found in youlaitech youlai-mall 1.0.0/2.0.0. Affected is the function getById/updateAddress/deleteAddress of the file /mall-ums/app-api/v1/addresses/. Executing manipulation can lead to improper control of dynamically-identified variables. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.